ISPE delivers technical and operational solutions to support across the global pharmaceutical and biopharmaceutical industry in the manufacture of quality medicines for patients.
ISPE’s FOYA program recognizes state-of-the-art projects using innovative technologies to improve the quality of products, reduce the cost of producing high-quality medicines, and demonstrate advances in project delivery for the benefit of humanity.
ISPE has announced the establishment of the ISPE Radiopharmaceuticals Community of Practice (CoP). This initiative intends to respond to the rapid growth and unique complexities of the radiopharmaceuticals field, which is critically advancing precision medicine for conditions such as cancer.
Advanced therapy medicinal products (ATMPs) are redefining what’s possible in medicine, but their promise comes with a challenge the industry can no longer afford to postpone: how to scale manufacturing in a way that is cost-effective, resilient, and patient-ready.